EpiPen maker Mylan to pay $465M to settle claims it overbilled Medicaid
October 07, 2016 at 20:22 PM EDT
Doug G. Ware CANONSBURG, Pa., Oct. 7 (UPI) -- Embattled pharma company Mylan agreed Friday to pay nearly a half-million dollars to settle claims it overbilled Medicaid for its life-saving EpiPen product.
